Abstract
Purpose of Review
To provide an updated review of the pathophysiology, diagnosis, and management of migraine with aura.
Recent Findings
Thalamic and other subcortical regions may play a role in the pathophysiology of migraine. There is inter-patient and intra-patient attack variability in the characteristics of typical aura especially visual aura symptoms. Migraine with brainstem aura may originate cortically. Migraine with retinal aura may be associated with structural and functional changes in the retina.
Summary
Although cortical spreading depression (CSD) continues to be the predominant theory surrounding the pathophysiology of migraine with aura, the exact mechanism of action of CSD and its role in relation of all phases of migraine including features of aura are not fully understood. Novel experimental models and newer diagnostic tools including neuroimaging are currently being used to enhance of understanding of migraine with and without aura. Transient ischemia attacks, stroke, and epilepsy should be considered in your differential diagnosis of migraine with aura. There are no specific therapies for migraine with aura.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58(Suppl 1):4–16.
Leao AAP, Morison RS. Propagation of spreading cortical depression. J Neurophysiol. 1945;8(1):33–45.
Bolay H, Vuralli D, Goadsby PJ. Aura and head pain: relationship and gaps in the translational models. J Headache Pain. 2019;20(1):94 Excellent review highlighting our current understanding of migraine with aura including cortical spreading depression and its limitations.
Goadsby PJ, Holland PR. An update: pathophysiology of migraine. Neurol Clin. 2019;37(4):651–71 Excellent review of migraine pathophysiology in all phases including aura phase.
Harriott AM, Takizawa T, Chung DY, Chen SP. Spreading depression as a preclinical model of migraine. J Headache Pain. 2019;20(1):45.
Chung DY, Sugimoto K, Fischer P, Bohm M, Takizawa T, Sadeghian H, et al. Real-time non-invasive in vivo visible light detection of cortical spreading depolarizations in mice. J Neurosci Methods. 2018;309:143–6.
Houben T, Loonen IC, Baca SM, Schenke M, Meijer JH, Ferrari MD, et al. Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice. J Cereb Blood Flow Metab. 2017;37(5):1641–55.
Charles A, Hansen JM. Migraine aura: new ideas about cause, classification, and clinical significance. Curr Opin Neurol. 2015;28(3):255–60.
Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98(8):4687–92.
Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, et al. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron. 2009;61(5):762–73.
Bolay H, Berman NE, Akcali D. Sex-related differences in animal models of migraine headache. Headache. 2011;51(6):891–904.
Hadjikhani N, Vincent M. Neuroimaging clues of migraine aura. J Headache Pain. 2019;20(1):32.
Russo A, Silvestro M, Tessitore A, Tedeschi G. Recent insights in migraine with aura: a narrative review of advanced neuroimaging. Headache. 2019;59(4):637–49.
Krebs C, Weinberg J, Akesson E, Dilli E. Lippincott illustrated reviews: neuroscience. 2nd ed. Alphen aan den Rijn: Wolters Kluwer; 2017.
Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137(Pt 1):232–41.
Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987–93.
Hougaard A, Amin FM, Larsson HB, Rostrup E, Ashina M. Increased intrinsic brain connectivity between pons and somatosensory cortex during attacks of migraine with aura. Hum Brain Mapp. 2017;38(5):2635–42.
Vinogradova LV. Initiation of spreading depression by synaptic and network hyperactivity: insights into trigger mechanisms of migraine aura. Cephalalgia. 2018;38(6):1177–87.
Lindblad M, Hougaard A, Amin FM, Ashina M. Can migraine aura be provoked experimentally? A systematic review of potential methods for the provocation of migraine aura. Cephalalgia. 2017;37(1):74–88.
International Headache Society Classification Committee. The international classification of headache disorders. 3rd edition. Cephalalgia : an international journal of headache. 2018;38:1–211.
Viana M, Sances G, Linde M, Ghiotto N, Guaschino E, Allena M, et al. Clinical features of migraine aura: results from a prospective diary-aided study. Cephalalgia. 2017;37(10):979–89 Excellent review on clinical features of visual aura based on prospective study of 72 patients.
Hansen JM, Baca SM, Vanvalkenburgh P, Charles A. Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording. Brain. 2013;136(Pt 12):3589–95.
Viana M, Sances G, Linde M, Nappi G, Khaliq F, Goadsby PJ, et al. Prolonged migraine aura: new insights from a prospective diary-aided study. J Headache Pain. 2018;19(1):77.
Viana M, Tronvik EA, Do TP, Zecca C, Hougaard A. Clinical features of visual migraine aura: a systematic review. J Headache Pain. 2019;20(1):64.
Yamani N, Chalmer MA, Olesen J. Migraine with brainstem aura: defining the core syndrome. Brain. 2019;142(12):3868–75.
Demarquay G, Ducros A, Montavont A, Mauguiere F. Migraine with brainstem aura: why not a cortical origin? Cephalalgia. 2018;38(10):1687–95.
Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology. 2006;66(6):880–6.
Grosberg BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia. 2006;26(11):1275–86.
El Youssef N, Maalouf N, Mourad A, Saade J, Khoury M. Teaching neuroimages: retinal migraine in action. Neurology. 2018;90(11):e992.
Chang M, Phasukkijwatana N, Garrity S, Pineles S, Rahimi M, Sarraf D, et al. Foveal and peripapillary vascular decrement in migraine with aura demonstrated by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58:5477–84.
El-Shazly AAE, Farweez YA, Hamdi MM, El-Sherbiny NE. Pattern visual evoked potential, pattern electroretinogram, and retinal nerve fiber layer thickness in patients with migraine during and after aura. Curr Eye Res. 2017;42(9):1327–32.
Kurth T, Chabriat H, Bousser M-G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012;11(1):92–100.
Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457–70.
Pelzer N, Haan J, Stam AH, Vijfhuizen LS, Koelewijn SC, Smagge A, et al. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology. 2018;90(7):e575–e82.
de Boer I, van den Maagdenberg A, Terwindt GM. Advance in genetics of migraine. Curr Opin Neurol. 2019;32(3):413–21.
Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856–66.
Liu L, Yu Y, He J, Guo L, Li H, Teng J. Effects of MTHFR C677T and A1298C polymorphisms on migraine susceptibility: a meta-analysis of 26 studies. Headache. 2019;59(6):891–905.
Mathew PG, Robertson CE. No laughing matter: gelastic migraine and other unusual headache syndromes. Curr Pain Headache Rep. 2016;20(5):32.
Erdal Y, Emre U, Cimen Atalar A, Gunes T. Alien hand syndrome and migraine with aura: a case report. Cephalalgia. 2018;38(13):1984–7.
Jion YI, Grosberg BM, Evans RW. Phantosmia and migraine with and without headache. Headache. 2016;56(9):1494–502.
Evans RW, Mitsias PD. Headache at onset of acute cerebral ischemia. Headache. 2009;49(6):902–8.
Shams P, Plant G. Migraine-like visual aura due to focal cerebral lesions: case series and review. Surv Ophthalmol. 2011;56(2):135–61.
Rajapakse T, Buchhalter J. The borderland of migraine and epilepsy in children. Headache. 2016;56:1071–80.
Bigal ME, Lipton RB, Cohen J, Silberstein SD. Epilepsy and migraine. Epilepsy Behav. 2003;4:13–24.
Terrin A, Toldo G, Ermani M, Mainardi F, Maggioni F. When migraine mimics stroke: a systematic review. Cephalalgia. 2018;38(14):2068–78.
Coutts SB, Moreau F, Asdaghi N, Boulanger JM, Camden MC, Campbell BCV, et al. Rate and prognosis of brain ischemia in patients with lower-risk transient or persistent minor neurologic events. JAMA Neurol. 2019;76(12):1439–45. Erratum published January 13, 2020. https://doi.org/10.1001/jamaneurol.2019.3063.
Coutts SB, Moreau F, Asdaghi N, Boulanger JM, Camden MC, Campbell BCV, et al. Rate and prognosis of brain ischemia in patients with lower-risk transient or persistent minor neurologic events [supplemental material]. JAMA Neurol. 2019;76:1439.
West BH, Noureddin N, Mamzhi Y, Low CG, Coluzzi AC, Shih EJ, et al. Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke. Stroke. 2018;49(5):1123–8.
Snijder RJ, Luermans JG, de Heij AH, Thijs V, Schonewille WJ, Van De Bruaene A, et al. Patent foramen ovale with atrial septal aneurysm is strongly associated with migraine with aura: a large observational study. J Am Heart Assoc. 2016;5(12).
Tobis JM, Charles A, Silberstein SD, Sorensen S, Maini B, Horwitz PA, et al. Percutaneous closure of patent foramen Ovale in patients with migraine: the PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–74.
Hartl E, Remi J, Noachtar S. Two patients with visual aura–migraine, epilepsy, or migralepsy? Headache. 2015;55(8):1148–51.
Panayiotopolous CP, Sharoqi A. Occipital seizures imitating migraine aura. J R Soc Med. 1997;90:255–7.
Hartl E, Gonzalez-Victores JA, Remi J, Schankin CJ, Noachtar S. Visual auras in epilepsy and migraine–an analysis of clinical characteristics. Headache. 2017;57(6):908–16.
Kingston WS, Schwedt TJ. The relationship between headaches with epileptic and non-epileptic seizures: a narrative review. Curr Pain Headache Rep. 2017;21(3):17.
Mastria G, Mancini V, Vigano A, De Sanctis R, Letteri F, Toscano M, et al. Temporal-occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura. Neurocase. 2018;24(5–6):242–4.
MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke. 2007;38(9):2438–45.
Bousser M-G, Welch KMA. Relation between migraine and stroke. Lancet Neurol. 2005;4(9):533–42.
Calhoun AH. Hormonal contraceptives and migraine with aura-is there still a risk? Headache. 2017;57(2):184–93.
Sheikh HU, Pavlovic J, Loder E, Burch R. Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: a systematic review. Headache. 2018;58(1):5–21.
Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216(5):489.e1–7.
Dodick DW. Review of comorbidities and risk factors for development of migraine complications (infarct and chronic migraine). Cephalalgia. 2009;29(Suppl. 3):7–14.
World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva: World Health Organization; 2004.
American College of Obstetrics and Gynecology Practice Bulletins. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133(2):e128–e43.
Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis MK. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94(6):630–40.
Petrusic I, Viana M, Dakovic M, JGoadsby P, Zidverc-Trajkovic J. Proposal for a migraine aura complexity score. Cephalalgia. 2019;39(6):732–41.
Vinciguerra L, Cantone M, Lanza G, Bramanti A, Santalucia P, Puglisi V, et al. Migrainous infarction and cerebral vasospasm: case report and literature review. J Pain Res. 2019;12:2941–50.
Laurell K, Artto V, Bendtsen L, Hagen K, Kallela M, Meyer EL, et al. Migrainous infarction: a Nordic multicenter study. Eur J Neurol. 2011;18(10):1220–6.
Wolf ME, Szabo K, Griebe M, Forster A, Gass A, Hennerici MG, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 2011;76:1911–7.
Arboix A, Gonzalez-Peris S, Grive E, Sanchez MJ, Comes E. Cortical laminar necrosis related to migrainous cerebral infarction. World J Clin Cases. 2013;1(8):256–9.
Pringsheim T, Davenport JW, Mackie G, Worthington I, Aubé M, Suzanne CN, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(Suppl 2):S1–2.
Artto V, Nissila M, Wessman M, Palotie A, Farkkila M, Kallela M. Treatment of hemiplegic migraine with triptans. Eur J Neurol. 2007;14(9):1053–6.
Mathew PG, Klein BC. Getting to the heart of the matter: migraine, triptans, DHE, ditans, CGRP antibodies, first/second-generation gepants, and cardiovascular risk. Headache. 2019;59(8):1421–6.
Hansen J, Goadsby PJ, Charles A. Reduced efficacy of sumatriptan in migraine with aura vs without aura. Neurology. 2015;84:1880–5.
Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG, Tonabersat TONSG. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia. 2009;29(7):742–50.
Anne W, Hauge MSA, Schytz HW, Christensen K, Olesen J. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol. 2009;8:718–23.
Hansen JM, Charles A. Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs. J Headache Pain. 2019;20(1):96 Excellent review of available evidence for treatments in migraine aura.
Cuadrado ML, Aledo-Serrano A, Lopez-Ruiz P, Gutierrez-Viedma A, Fernandez C, Orviz A, et al. Greater occipital nerve block for the acute treatment of prolonged or persistent migraine aura. Cephalalgia. 2017;37(8):812–8.
Hansen JM, Hauge AW, Olesen J, Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30(10):1179–86.
Lipton R, Dodick DW, Silberstein S, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–80.
De Icco R, Bitetto V, Martinelli D, Allena M, Guaschino E, Bottiroli S, et al. Noninvasive peripheral vagal nerve stimulation prevents migraine aura: a case report. Cephalalgia Reports. 2019;2:251581631985560.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Headache
Rights and permissions
About this article
Cite this article
Lai, J., Dilli, E. Migraine Aura: Updates in Pathophysiology and Management. Curr Neurol Neurosci Rep 20, 17 (2020). https://doi.org/10.1007/s11910-020-01037-3
Published:
DOI: https://doi.org/10.1007/s11910-020-01037-3